As salivary duct carcinoma is frequently the worst histopathological type of parotid malignancy, additional therapies are needed or developed for this type of parotid malignancy, such as ADT, Her2-targeted therapy, and so on. The gene discussed is ERBB2; the disease is salivary duct carcinoma.